Literature DB >> 21685320

Functional dissection of a Candida albicans zinc cluster transcription factor, the multidrug resistance regulator Mrr1.

Sabrina Schubert1, Christina Popp, P David Rogers, Joachim Morschhäuser.   

Abstract

The overexpression of the MDR1 gene, which encodes a multidrug efflux pump of the major facilitator superfamily, is a frequent cause of resistance to the widely used antimycotic agent fluconazole and other toxic compounds in the pathogenic yeast Candida albicans. The zinc cluster transcription factor Mrr1 controls MDR1 expression in response to inducing chemicals, and gain-of-function mutations in MRR1 are responsible for the constitutive MDR1 upregulation in fluconazole-resistant C. albicans strains. To understand how Mrr1 activity is regulated, we identified functional domains of this transcription factor. A hybrid protein consisting of the N-terminal 106 amino acids of Mrr1 and the transcriptional activation domain of Gal4 from Saccharomyces cerevisiae constitutively induced MDR1 expression, demonstrating that the DNA binding domain is sufficient to target Mrr1 to the MDR1 promoter. Using a series of C-terminal truncations and systematic internal deletions, we could show that Mrr1 contains multiple activation and inhibitory domains. One activation domain (AD1) is located in the C terminus of Mrr1. When fused to the tetracycline repressor TetR, this distal activation domain induced gene expression from a TetR-dependent promoter. The deletion of an inhibitory region (ID1) located near the distal activation domain resulted in constitutive activity of Mrr1. The additional removal of AD1 abolished the constitutive activity, but the truncated Mrr1 still could activate the MDR1 promoter in response to the inducer benomyl. These results demonstrate that the activity of Mrr1 is regulated in multiple ways and provide insights into the function of an important mediator of drug resistance in C. albicans.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21685320      PMCID: PMC3165443          DOI: 10.1128/EC.05100-11

Source DB:  PubMed          Journal:  Eukaryot Cell        ISSN: 1535-9786


  37 in total

1.  An A643V amino acid substitution in Upc2p contributes to azole resistance in well-characterized clinical isolates of Candida albicans.

Authors:  Samantha J Hoot; Adam R Smith; Ryan P Brown; Theodore C White
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

Review 2.  Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation.

Authors:  Dominique Sanglard; Alix Coste; Sélène Ferrari
Journal:  FEMS Yeast Res       Date:  2009-09-07       Impact factor: 2.796

3.  A common drug-responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance.

Authors:  Michelle de Micheli; Jacques Bille; Christoph Schueller; Dominique Sanglard
Journal:  Mol Microbiol       Date:  2002-03       Impact factor: 3.501

4.  Differential requirement of the transcription factor Mcm1 for activation of the Candida albicans multidrug efflux pump MDR1 by its regulators Mrr1 and Cap1.

Authors:  Selene Mogavero; Arianna Tavanti; Sonia Senesi; P David Rogers; Joachim Morschhäuser
Journal:  Antimicrob Agents Chemother       Date:  2011-02-22       Impact factor: 5.191

Review 5.  Regulation of multidrug resistance in pathogenic fungi.

Authors:  Joachim Morschhäuser
Journal:  Fungal Genet Biol       Date:  2009-08-07       Impact factor: 3.495

Review 6.  A fungal family of transcriptional regulators: the zinc cluster proteins.

Authors:  Sarah MacPherson; Marc Larochelle; Bernard Turcotte
Journal:  Microbiol Mol Biol Rev       Date:  2006-09       Impact factor: 11.056

7.  A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans.

Authors:  Alix Coste; Vincent Turner; Françoise Ischer; Joachim Morschhäuser; Anja Forche; Anna Selmecki; Judith Berman; Jacques Bille; Dominique Sanglard
Journal:  Genetics       Date:  2006-02-01       Impact factor: 4.562

8.  Regulation of efflux pump expression and drug resistance by the transcription factors Mrr1, Upc2, and Cap1 in Candida albicans.

Authors:  Sabrina Schubert; Katherine S Barker; Sadri Znaidi; Sabrina Schneider; Franziska Dierolf; Nico Dunkel; Malika Aïd; Geneviève Boucher; P David Rogers; Martine Raymond; Joachim Morschhäuser
Journal:  Antimicrob Agents Chemother       Date:  2011-03-14       Impact factor: 5.191

9.  Transcriptional activation domains of the Candida albicans Gcn4p and Gal4p homologs.

Authors:  Mikhail Martchenko; Anastasia Levitin; Malcolm Whiteway
Journal:  Eukaryot Cell       Date:  2006-12-08

10.  An A643T mutation in the transcription factor Upc2p causes constitutive ERG11 upregulation and increased fluconazole resistance in Candida albicans.

Authors:  Clemens J Heilmann; Sabrina Schneider; Katherine S Barker; P David Rogers; Joachim Morschhäuser
Journal:  Antimicrob Agents Chemother       Date:  2009-11-02       Impact factor: 5.191

View more
  16 in total

1.  UPC2 is universally essential for azole antifungal resistance in Candida albicans.

Authors:  Erin M Vasicek; Elizabeth L Berkow; Stephanie A Flowers; Katherine S Barker; P David Rogers
Journal:  Eukaryot Cell       Date:  2014-03-21

2.  Induction of Candida albicans drug resistance genes by hybrid zinc cluster transcription factors.

Authors:  Sabrina Schneider; Joachim Morschhäuser
Journal:  Antimicrob Agents Chemother       Date:  2014-11-10       Impact factor: 5.191

3.  Candida albicans Swi/Snf and Mediator Complexes Differentially Regulate Mrr1-Induced MDR1 Expression and Fluconazole Resistance.

Authors:  Zhongle Liu; Lawrence C Myers
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

Review 4.  Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans.

Authors:  Andrew T Nishimoto; Cheshta Sharma; P David Rogers
Journal:  J Antimicrob Chemother       Date:  2020-02-01       Impact factor: 5.790

5.  Disruption of the transcriptional regulator Cas5 results in enhanced killing of Candida albicans by Fluconazole.

Authors:  Erin M Vasicek; Elizabeth L Berkow; Vincent M Bruno; Aaron P Mitchell; Nathan P Wiederhold; Katherine S Barker; P David Rogers
Journal:  Antimicrob Agents Chemother       Date:  2014-09-02       Impact factor: 5.191

6.  Inducible and constitutive activation of two polymorphic promoter alleles of the Candida albicans multidrug efflux pump MDR1.

Authors:  Christoph Sasse; Rebecca Schillig; Alexandra Reimund; Julia Merk; Joachim Morschhäuser
Journal:  Antimicrob Agents Chemother       Date:  2012-05-21       Impact factor: 5.191

7.  Transcriptional Response of Candida auris to the Mrr1 Inducers Methylglyoxal and Benomyl.

Authors:  Amy R Biermann; Deborah A Hogan
Journal:  mSphere       Date:  2022-04-27       Impact factor: 5.029

8.  SAGA/ADA complex subunit Ada2 is required for Cap1- but not Mrr1-mediated upregulation of the Candida albicans multidrug efflux pump MDR1.

Authors:  Bernardo Ramírez-Zavala; Selene Mogavero; Eva Schöller; Christoph Sasse; P David Rogers; Joachim Morschhäuser
Journal:  Antimicrob Agents Chemother       Date:  2014-06-16       Impact factor: 5.191

9.  The evolution of drug resistance in clinical isolates of Candida albicans.

Authors:  Christopher B Ford; Jason M Funt; Darren Abbey; Luca Issi; Candace Guiducci; Diego A Martinez; Toni Delorey; Bi Yu Li; Theodore C White; Christina Cuomo; Reeta P Rao; Judith Berman; Dawn A Thompson; Aviv Regev
Journal:  Elife       Date:  2015-02-03       Impact factor: 8.140

Review 10.  Multidrug resistance in fungi: regulation of transporter-encoding gene expression.

Authors:  Sanjoy Paul; W Scott Moye-Rowley
Journal:  Front Physiol       Date:  2014-04-16       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.